Loading organizations...
Lyell Immunopharma was founded by Scott Boyken (Co-Founder, Co-Director of Protein & Cell Engineering).
Lyell Immunopharma was founded by Scott Boyken (Co-Founder, Co-Director of Protein & Cell Engineering).
Key people at Lyell Immunopharma.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 31, 2021 | Outpace Bio | $30.0M Series A | Lyell Immunopharma | — |
| Mar 18, 2020 | Cero Therapeutics | $40.0M Series A | — | Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments |
| Mar 17, 2020 | Eureka Therapeutics | $45.0M Series E | Richard Klausner | — |